{"title":"Effects of low‐dose scopolamine on locomotor activity: No dissociation between cognitive and non‐effects","authors":"G. Poorheidari, J. Pratt, Nima Dehghani","doi":"10.1002/NRC.10049","DOIUrl":null,"url":null,"abstract":"Attempts have been made to dissociate the cognitive effects of scopolamine from its non-cognitive effects. It has been suggested that low doses of scopolamine may induce memory impairment without inducing significant non-cognitive effects. We therefore tested changes in locomotor activity (as a non-cognitive effect) in rats treated with low-dose scopolamine (which is believed to induce cognitive effects only). \n \n \n \nIn this study, locomotor activity (as a non-cognitive effect) induced by low doses of this drug was evaluated by using two methods and rat strains. In the first study (circular box method, an automated open-field), scopolamine hydrobromide (HBr), scopolamine methylbromide (MeBr) or saline was injected subcutaneously into male Sprague-Dawley rats. After 30 min, rats were put into an automated open-field and locomotor activity was quantified by recording interruptions of infrared beams, with print-outs every 2 min for 16 min. Locomotor activity was assessed by summing these recordings. In the second study (closed platform), scopolamine HBr or saline was injected intraperitoneally into male Long-Evans rats. Twenty minutes later, the rats were placed in the center of a square-shaped closed platform (with 3×3 divisions). Locomotor activity was defined as the sum of crossings (traversing of four paws of the rat from one area into another of nine) and rears, which were recorded every 5 min for 20 min. \n \n \n \nResults from the circular box study showed that scopolamine HBr produced a marked increase in locomotor activity whereas scopolamine MeBr produced a non-significant decrease in locomotor activity. The closed platform data also demonstrated that scopolamine HBr increased locomotor activity significantly. \n \n \n \nThese data show that scopolamine can induce non-cognitive effects (such as increased locomotor activity), even at low doses. Our results also imply that the increase in locomotor activity is mediated centrally.","PeriodicalId":19198,"journal":{"name":"Neuroscience Research Communications","volume":"37 4","pages":"165-174"},"PeriodicalIF":0.0000,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/NRC.10049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
Abstract
Attempts have been made to dissociate the cognitive effects of scopolamine from its non-cognitive effects. It has been suggested that low doses of scopolamine may induce memory impairment without inducing significant non-cognitive effects. We therefore tested changes in locomotor activity (as a non-cognitive effect) in rats treated with low-dose scopolamine (which is believed to induce cognitive effects only).
In this study, locomotor activity (as a non-cognitive effect) induced by low doses of this drug was evaluated by using two methods and rat strains. In the first study (circular box method, an automated open-field), scopolamine hydrobromide (HBr), scopolamine methylbromide (MeBr) or saline was injected subcutaneously into male Sprague-Dawley rats. After 30 min, rats were put into an automated open-field and locomotor activity was quantified by recording interruptions of infrared beams, with print-outs every 2 min for 16 min. Locomotor activity was assessed by summing these recordings. In the second study (closed platform), scopolamine HBr or saline was injected intraperitoneally into male Long-Evans rats. Twenty minutes later, the rats were placed in the center of a square-shaped closed platform (with 3×3 divisions). Locomotor activity was defined as the sum of crossings (traversing of four paws of the rat from one area into another of nine) and rears, which were recorded every 5 min for 20 min.
Results from the circular box study showed that scopolamine HBr produced a marked increase in locomotor activity whereas scopolamine MeBr produced a non-significant decrease in locomotor activity. The closed platform data also demonstrated that scopolamine HBr increased locomotor activity significantly.
These data show that scopolamine can induce non-cognitive effects (such as increased locomotor activity), even at low doses. Our results also imply that the increase in locomotor activity is mediated centrally.